422 results on '"Hohmann, Andrea G."'
Search Results
2. Cannabinoid CB2 receptors in primary sensory neurons are implicated in CB2 agonist-mediated suppression of paclitaxel-induced neuropathic nociception and sexually-dimorphic sparing of morphine tolerance
3. A monoacylglycerol lipase inhibitor showing therapeutic efficacy in mice without central side effects or dependence
4. NAAA-regulated lipid signaling governs the transition from acute to chronic pain
5. Conditional deletion of CB2 cannabinoid receptors from peripheral sensory neurons eliminates CB2-mediated antinociceptive efficacy in a mouse model of carrageenan-induced inflammatory pain
6. Engineering human spinal microphysiological systems to model opioid-induced tolerance
7. Negative allosteric modulation of CB1 cannabinoid receptor signalling decreases intravenous morphine self‐administration and relapse in mice.
8. CB1Cannabinoid Receptor Agonists Induce Acute Respiratory Depression in Awake Mice
9. Inhaled Cannabis Suppresses Chemotherapy-Induced Neuropathic Nociception by Decoupling the Raphe Nucleus: A Functional Imaging Study in Rats
10. Negative allosteric modulation of CB1 cannabinoid receptor signaling decreases intravenous morphine self-administration and relapse in mice
11. Negative allosteric modulation of cannabinoid CB1receptor signaling suppresses opioid-mediated tolerance and withdrawal without blocking opioid antinociception
12. Cannabidiol has a unique effect on global brain activity: a pharmacological, functional MRI study in awake mice
13. A Lipid Gate for the Peripheral Control of Pain
14. Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence
15. Activation of Type 5 Metabotropic Glutamate Receptors and Diacylglycerol Lipase-α Initiates 2-Arachidonoylglycerol Formation and Endocannabinoid-Mediated Analgesia
16. Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain
17. Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism
18. A role for 2-arachidonoylglycerol and endocannabinoid signaling in the locomotor response to novelty induced by olfactory bulbectomy
19. The chemotherapeutic agent paclitaxel selectively impairs reversal learning while sparing prior learning, new learning and episodic memory
20. An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters
21. Role of the basolateral nucleus of the amygdala in endocannabinoid-mediated stress-induced analgesia
22. Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia
23. An endocannabinoid mechanism for stress-induced analgesia
24. Increased Mortality, Hypoactivity, and Hypoalgesia in Cannabinoid CB1 Receptor Knockout Mice
25. Role of Cannabinoids in Pain Management
26. A protocol for the systematic review and meta-analysis of studies in which cannabinoids were tested for antinociceptive effects in animal models of pathological or injury-related persistent pain
27. Control of pain initiation by endogenous cannabinoids
28. Peripheral sensory neuron CB2 cannabinoid receptors are necessary for both CB2-mediated antinociceptive efficacy and sparing of morphine tolerance in a mouse model of anti-retroviral toxic neuropathy
29. Negative allosteric modulation of CB1 cannabinoid receptor signaling suppresses opioid-mediated reward
30. Role of Cannabinoids in Pain Management
31. Engineering human spinal microphysiological systems to model opioid-induced tolerance
32. Inhibition of PSD95‐nNOS protein–protein interactions decreases morphine reward and relapse vulnerability in rats
33. Endocannabinoid Mechanisms of Pain Modulation
34. Peripheral sensory neuron CB2 cannabinoid receptors are necessary for both CB2-mediated antinociceptive efficacy and sparing of morphine tolerance in a mouse model of neuropathic pain
35. The cannabinoid system and pain
36. The chemotherapeutic agent paclitaxel selectively impairs learning while sparing source memory and spatial memory
37. Engineering human spinal microphysiological systems to model opioid-induced tolerance.
38. A limited access oral oxycodone paradigm produces physical dependence and mesocorticolimbic region-dependent increases in DeltaFosB expression without preference
39. Self-medication of a cannabinoid CB 2 agonist in an animal model of neuropathic pain
40. Selective targeting of NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in rodents
41. Source memory in rats is impaired by an NMDA receptor antagonist but not by PSD95-nNOS protein–protein interaction inhibitors
42. Role of Cannabinoids in Pain Management
43. A peripheral CB2 cannabinoid receptor mechanism suppresses chemotherapy-induced peripheral neuropathy: evidence from a CB2 reporter mouse
44. Fecal microbiota transplantation and antibiotic treatment attenuate naloxone-precipitated opioid withdrawal in morphine-dependent mice
45. An adolescent rat model of vincristine-induced peripheral neuropathy
46. Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside
47. A systematic review and meta-analysis of cannabis-based medicines, cannabinoids and endocannabinoid system modulators tested for antinociceptive effects in animal models of injury-related or pathological persistent pain
48. Review of the Role of the Brain in Chemotherapy-Induced Peripheral Neuropathy
49. Additional file 1 of Cannabidiol has a unique effect on global brain activity: a pharmacological, functional MRI study in awake mice
50. Selective targeting of NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in rodents
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.